http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022232360-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9ab34b5a69d7f227f12ca87d66d27f8 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16 |
filingDate | 2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21c8db809709e97af655a579d7ace5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7192b4c198851c1b67cc2356ceeb4017 |
publicationDate | 2022-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2022232360-A1 |
titleOfInvention | Small molecule modulators of glucocerebrosidase activity and uses thereof |
abstract | Provided herein are compounds that modulate glucocerebrosidase (GCase), an enzyme whose activity is associated with neurological diseases and disorders (e.g., Gaucher's disease, Parkinson's disease). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating GCase-related diseases and disorders (e.g., Gaucher's disease, Parkinson's disease) with the compounds in a subject, by administering the compounds and/or compositions described herein. |
priorityDate | 2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 832.